Pharmacological therapy of neuroendocrine tumors

被引：1
作者：
Rinke, Anja [1 ]
Ricci, Sergio [1 ]
Bajetta, Emilio [1 ]
Jelic, Svetislav [1 ]
机构：
[1] Univ Marburg, Dept Internal Med, Div Gastroenterol & Endocrinol, D-3550 Marburg, Germany
来源：
TUMORI | 2010年 / 96卷 / 05期
关键词：
SOMATOSTATIN ANALOGS; OCTREOTIDE; LANREOTIDE; EFFICACY;
D O I：
10.1177/030089161009600538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：847 / 849
页数：3
相关论文
共 13 条
  • [1] Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
    Aparicio, T
    Ducreux, M
    Baudin, E
    Sabourin, JC
    De Baere, T
    Mitry, E
    Schlumberger, M
    Rougier, P
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) : 1014 - 1019
  • [2] Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours
    Arnold, R
    Trautmann, ME
    Creutzfeldt, W
    Benning, R
    Benning, M
    Neuhaus, C
    Jurgensen, R
    Stein, K
    Schafer, H
    Bruns, C
    Dennler, HJ
    [J]. GUT, 1996, 38 (03) : 430 - 438
  • [3] DiBartolomeo M, 1996, CANCER-AM CANCER SOC, V77, P402, DOI 10.1002/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO
  • [4] 2-4
  • [5] Ducreux M, 2000, AM J GASTROENTEROL, V95, P3276
  • [6] High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects
    Eriksson, B
    Renstrup, J
    Imam, H
    Oberg, K
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (10) : 1041 - 1044
  • [7] Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
    Panzuto, F
    Di Fonzo, M
    Iannicelli, E
    Sciuto, R
    Maini, CL
    Capurso, G
    Milione, M
    Cattaruzza, MS
    Falconi, M
    David, V
    Ziparo, V
    Pederzoli, P
    Bordi, C
    Delle Fave, G
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (03) : 461 - 466
  • [8] Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
    Rinke, Anja
    Mueller, Hans-Helge
    Schade-Brittinger, Carmen
    Klose, Klaus-Jochen
    Barth, Peter
    Wied, Matthias
    Mayer, Christina
    Aminossadati, Behnaz
    Pape, Ulrich-Frank
    Blaeker, Michael
    Harder, Jan
    Arnold, Christian
    Gress, Thomas
    Arnold, Rudolf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4656 - 4663
  • [9] SALTZ L, 1993, CANCER, V72, P244, DOI 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO
  • [10] 2-Q
12